Researchers are harnessing the power of high-throughput genomics to conduct large-scale, global genetic analyses. This research often focuses on multifactorial genetic discovery of disease risk markers, and may involve looking for changes in genetic variants such as single nucleotide polymorphisms (SNPs), indels, splice variants, structural variants, and methylation markers.
High-throughput genomics studies with tens to hundreds of thousands of samples require fast, cost-effective tools. Illumina offers high-throughput genomic analysis technologies with comprehensive sample-to-analysis solutions and exceptional collaborative expertise to meet these needs.
Sequencing by synthesis is a massively parallel sequencing technology that has launched the next generation in genomic sciences.
Our high-density microarray technology offers trusted data quality and exceptional coverage of valuable genomic regions, making Illumina arrays the platform of choice by leading institutions for high-throughput screening and large-scale genotyping research programs.
Recent advances in sequencing technologies have allowed for the development of high-throughput genomics-based strategies to assay GWAS SNPs for potential functional relevance. Powerful combinations of high-throughput experimental assays, single-cell approaches, and computational analyses are accelerating the ability to link variants to function, and, by extension, link genotype to phenotype.View Webinar
For labs preparing large quantities of NGS libraries, liquid-handling robots and other automation solutions provide a good option.
Sample multiplexing allows large numbers of NGS libraries to be pooled and sequenced simultaneously during a single run.
Find information and resources to help simplify the process of setting up an informatics infrastructure and data analysis pipeline.
Learn how you can benefit from a laboratory information management system (LIMS) optimized for genomics, and find out what to look for.
Large-scale genotyping with arrays can identify variants associated with disease risk in large cohorts or populations.
Process more samples to improve statistical power. Get multidimensional insights and increase analytical resolution in a scalable, cost-effective manner.
Prenetics created a high-throughput genotyping laboratory to serve its growing customer base in Southeast Asia.Read Article
The Breast Cancer Atlas Project involves cellular genomics studies of over a million individual breast cancer cells to help researchers identify potential therapeutic targets.Read Interview
Resource planning and automated genotyping workflows allowed GPBio to achieve immediate efficiency and throughput gains.Read Article
National population genomics programs seek to integrate large, diverse data sets, combining clinical information with genomic data at scale.Learn More
Genomic technologies are introducing new avenues for understanding complex disease etiology on a molecular level.Learn More
NGS can help pharmaceutical scientists identify potential drug targets and support development of targeted therapies.Learn More